• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis and therapeutic application of crosstalk between innate immunity and acquired immunity in viral hepatitis.

Research Project

Project/Area Number 17590688
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionAichi Medical University

Principal Investigator

ISHIKAWA Tetsuya  Aichi Medical University, School of Medicine, Faculty of Medicine, Associate Professor (10288508)

Co-Investigator(Kenkyū-buntansha) KAKUMU Shinichi  Aichi Medical University, School of Medicine, Faculty of Medicine, Professor (10115545)
OKUMURA Akihiko  Aichi Medical University, School of Medicine, Faculty of Medicine, Lecturer (70288512)
ITO Hiroyasu  Gifu University, Graduate School of Medicine, Lecturer (80373075)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2006: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2005: ¥2,400,000 (Direct Cost: ¥2,400,000)
Keywordshepatitis B virus / transgenic mouse / NKT cell / cytotoxic T lymphocyte / α-galactosylceramide / IL-2 / CD40 / CD4OL / サイトカイン
Research Abstract

Natural killer T (NKT) cells are one of the major cell populations in the liver and thought to play important roles on immune-pathogenesis of hepatitis. On the other hand, cytotoxic T lymphocytes (CTLs) are thought to be major effectors for clearing viruses in acute infections including hepatitis B virus(HBV). Persistent HBV infection is characterized by a lack of or a weak CTL response to HBV, which is thought to reflect tolerance to HBV antigens. In the present study, we found that alpha-galactosylceramide (α-GalCer), a ligand for Vα14-positive NKT cells stropgly enhanced the induction and proliferation of HBV-specific CTLs by HBsAg. In HBsAg transgenic mice, which are thought to be tolerant to HBV-encoded antigens, administration of HBsAg or α-GalCer alone failed to induce HBsAg-specific CTLs, but co-administration of the both compounds did induce them. A blocking experiment using antibodies to cytokines and CD40 ligand showed that IL-2 and CD40/CD4OL interaction mediate the enhancement of CTL induction caused by α-GalCer through NKT cell activation. The crosstalk between innate and acquired immunity could be applied to the intractable infectious diseases like HBV infection.

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (14 results)

All 2007 2006 2005

All Journal Article (14 results)

  • [Journal Article] Combination therapy with lamivudine and HB vaccine on chronic hepatitis B2007

    • Author(s)
      Ishikawa T, Kakumu S.
    • Journal Title

      Hepatology Research 37

    • NAID

      10019566225

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Use of HB vaccine for the treatment of chronic hepatitis B2007

    • Author(s)
      Ishikawa T, Kakumu S.
    • Journal Title

      Hepatology Research 37

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Combination therapy with lamvudine and HB vaccine on chronic hepatitis B.2007

    • Author(s)
      Ishikawa T, Kakumu S.
    • Journal Title

      Hepatology Research 37

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Use of HB vaccine for the treatment of chronic hepatitis B.2007

    • Author(s)
      Ishikawa T, Kakumu S.
    • Journal Title

      Hepatology Research 37

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Expression of Toll-like receptors in chronic hepatitis C virus infection.2007

    • Author(s)
      Sato K, et al.
    • Journal Title

      J gastroenterol Hepatol (in press)

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infection2006

    • Author(s)
      Zhang Q, et. al.
    • Journal Title

      Hepatology Research 34

      Pages: 170-177

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] The SNAP-hyaluronan complex in serum from patients with chronic liver diseases caused by hepatitis virus infection2006

    • Author(s)
      Shen L, et. al.
    • Journal Title

      Hepatology Research 34

      Pages: 178-186

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection2006

    • Author(s)
      Ayada M, et. al.
    • Journal Title

      Hepatology Research 34

      Pages: 214-221

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] The SHAP-hyaluronan complex in serum from patients with chronic liver diseases caused by hepatitis virus infection.2006

    • Author(s)
      Shen L, et. al.
    • Journal Title

      Hepatology Research 34

      Pages: 178-186

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection.2006

    • Author(s)
      Ayada M, et. al.
    • Journal Title

      Hepatology Research 34

      Pages: 214-221

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection.2006

    • Author(s)
      Ayada M, et al.
    • Journal Title

      Hepatology Redsearch (in press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Changes on natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma2005

    • Author(s)
      Okumura A, et. al.
    • Journal Title

      Hepatology Research 32

      Pages: 213-217

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Changes on natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma.2005

    • Author(s)
      Okumura A, et. al.
    • Journal Title

      Hepatology Research 32

      Pages: 213-217

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Changes on natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma.2005

    • Author(s)
      Okumura A, et al.
    • Journal Title

      Hepatology Research 32

      Pages: 213-217

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi